Navigation Links
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Date:5/19/2009

er in Cincinnati, Ohio and a principal investigator for the TAXUS PERSEUS clinical trial evaluating the TAXUS Element Stent. "The Element Stent series is intended to provide a full range of DES solutions for interventional cardiologists, giving them the option to treat patients with a paclitaxel, everolimus or bare-metal stent. In my experience, the TAXUS Element Stent is a highly deliverable and conformable platform that has the potential to simplify complex procedures and improve outcomes."

"Our platinum chromium Element Stent series represents a significant leap forward in drug-eluting stent innovation," said David McFaul, Boston Scientific Senior Vice President, International. "This breakthrough technology combines a new alloy designed for coronary stenting, an innovative stent design and a new delivery system."

The TAXUS Element Stent System is currently being studied in the PERSEUS clinical trial program, which compares the TAXUS Element Stent System to the TAXUS(R) Express2(R) Stent System. The program includes the PERSEUS Workhorse and the PERSEUS Small Vessel arms. Both have finished recruiting patients and are estimated to be completed by the end of the year. The PROMUS Element Stent System is currently being studied in the PLATINUM clinical trial program, which compares the PROMUS Element Stent System to the PROMUS(R) Stent System, and is actively enrolling patients in the U.S., Europe and Japan.

While the Element Stent platform represents Boston Scientific's third-generation DES technology, the Company's fourth-generation DES is currently under development. Initial clinical data were presented at the Transcatheter Cardiovascular Therapeutics scientific symposium in 2008; global pivotal trials are expected to begin in 2010. This DES employs the Labcoat technology, which has an ultra thin biodegradable abluminal polymer that delivers a very low dose of paclitaxel to the wall of the treated vessel, and no polymer or drug on
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
2. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
5. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
6. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
7. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
10. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... DUBLIN and RALEIGH, N.C. ... subsidiary of Endo International plc (NASDAQ: ENDP ... BDSI ) announced today that they have ... Buccal Film to the U.S. Food and Drug Administration ... the management of pain severe enough to require daily, ...
(Date:12/22/2014)... Apnea Sciences ( www.apneasciences.com ) announced it ... Aliso Viejo , California.  Jimmy Fallon , ... and worldwide expansion, a new facility with expanded infrastructure ... snore cure have exceeded our expectations and thus required ... in 23 countries and will be increasing to 39 ...
(Date:12/22/2014)... LUXEMBOURG , Dec. 22, 2014  ConvaTec, a ... Paul Moraviec has been appointed Interim Chief Executive Officer ... Mr. Moraviec succeeds Ken Berger .  "The Board ... service in leading ConvaTec over the past three years," ... Board of Directors.  "We are confident that the company ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... , NASHVILLE, Tenn., Oct. 27 Cumberland Pharmaceuticals Inc. ... report third quarter 2009 financial results before the market opens ... live Internet webcast will be held on Tuesday, November 10, ... , To participate on the call, please dial 888-417-8462 (for ...
... Denver ophthalmologist recently became the first in Colorado to implant ... bar for patient care in the state while increasing the ... director of Cutarelli Vision in Denver and Fort Collins, said ... eye of a 70-year-old man whose cataracts in his left ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 3
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... can receive effective, less expensive care from a clinic that ... team of dedicated health care professionals, a new study shows. ... need either hospitalization or a trip to the emergency room ... at the University of Texas in Houston versus usual care, ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
(Date:12/25/2014)... Viejo, California (PRWEB) December 25, 2014 ... release of ProFire 5k. A fully customizable business presentation ... . , “Adding the ProFire 5k business tool, users ... Said Christina Austin, CEO of Pixel Film Studios. “ProFire ... look and style to add professionalism to a presentation” ...
(Date:12/24/2014)... AlignLife of Wauwatosa loves helping those in ... the holiday season, AlignLife looks forward to their annual toy ... Sara Mahalko-Leonhardt, owner of AlignLife. "It brings our patients as ... are able to give kids toys for Christmas who would ... generosity of our patients." , The 70 toys were donated ...
(Date:12/24/2014)... 25, 2014 Recently, iFitDress.com, a famous dress ... prom dresses under $150 . All these items are brand ... website has already been updated with the new range of ... ordered so far. All iFitDress.com’s designs are made according to ... using great materials. Every outfit from the company is handpicked ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2
... Dec. 11 Emerging Growth Equities, Ltd. initiates coverage ... BUY rating and a $9.00 price target. PolyMedix ... serious, life-threatening acute disorders. The Company,s leading clinical ... antagonist PMX-60056. , , ...
... training to ease their lower back pain are better off ... jogging, according to a University of Alberta study. , The ... a 60 per cent improvement in pain and function levels ... 16-week exercise program of resistance training using dumbbells, barbells and ...
... Nutritional Supplements,has developed a new revolutionary appetite and weight ... their desire to eat,and reduce their food intake, it ... less but still feel satisfied. Additionally, Trimma(TM),comes in an ... their chocolate and sweet cravings. , ...
... nation is facing, call center outsourcing services provider Outsourcing City remains ... to further save on its investments, the company is now offering ... telemarketing services. , ... Brea, CA (PRWEB) December 11, ...
... Human Immunology Center (RHIC) has been awarded a $4 ... of Allergy and Infection Disease (NIAID). The renewal enables ... a worldwide effort to standardize how researchers use complex ... discovery of new treatments. , When standardization ...
... Dec. 11 Intellx Inc. announces a 50%,price cut ... Intellx is one of four major condom makers ... USA, Inspiral(R). , ... Brian,Osterberg, "and the coalescence of growing popularity of our ...
Cached Medicine News:Health News:Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target 2Health News:Trimma(TM) Now Available in the United States for People Looking for a Delicious Way to Control Their Calories 2Health News:Free Trial of Call Center Outsourcing Services and Performance Based Telemarketing from Outsourcing City 2Health News:Free Trial of Call Center Outsourcing Services and Performance Based Telemarketing from Outsourcing City 3Health News:Immunology Center will continue to drive standard methods, better science 2Health News:Immunology Center will continue to drive standard methods, better science 3Health News:Immunology Center will continue to drive standard methods, better science 4Health News:Immunology Center will continue to drive standard methods, better science 5Health News:Intellx Bails Out Safe Sex 2
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... CARDIAC M Myoglobin assay for use ... The Cardiac reader analyzer is a ... include: always ready to use (stand-by ... batch specific data entered automatically using ...
IRMA kit for detection of the cardiac marker Myoglobin...
... The CALBIOTECH INC. (CBI) Prolactin ELISA kit ... prolactin in human serum or plasma. Human ... polypeptide hormone with a molecular weight of ... based on a solid phase direct sandwich ...
Medicine Products: